Journal Article

Do statins play a role in the early management of the acute coronary syndrome?

F.M Sacks

in European Heart Journal Supplements

Published on behalf of European Society of Cardiology

Volume 6, issue suppl_A, pages A32-A36
Published in print March 2004 | ISSN: 1520-765X
Published online March 2004 | e-ISSN: 1554-2815 | DOI: http://dx.doi.org/10.1016/j.ehjsup.2004.01.008
Do statins play a role in the early management of the acute coronary syndrome?

Show Summary Details

Preview

Acute coronary syndrome (ACS) is associated with a poor prognosis and, despite the availability of a number of treatment strategies, the incidence of subsequent serious complications following an acute event remains high. Although large, long-term clinical trials have established the benefits of statin therapy in the prevention of cardiovascular events and mortality, patients with recent ACS were excluded from these studies. Data from observational studies and a randomized controlled trial support the routine use of statins in ACS and highlight the association between early initiation and reductions in recurrent coronary events and mortality. Preclinical and clinical evidence also indicates that, in addition to their lipid-lowering effects, statins may reduce inflammation, improve endothelial function and increase plaque stability. Ongoing clinical trials with highly efficacious statins are expected to provide valuable information about the most appropriate agent and dose to improve the treatment of patients with ACS.

Keywords: Acute coronary syndrome; Myocardial infarction; Angina; Statins

Journal Article.  2983 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.